These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 17440109)

  • 1. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion.
    Song P; Sekhon HS; Lu A; Arredondo J; Sauer D; Gravett C; Mark GP; Grando SA; Spindel ER
    Cancer Res; 2007 Apr; 67(8):3936-44. PubMed ID: 17440109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma.
    Song P; Sekhon HS; Jia Y; Keller JA; Blusztajn JK; Mark GP; Spindel ER
    Cancer Res; 2003 Jan; 63(1):214-21. PubMed ID: 12517800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of catalytically inactive phospholipase Cbeta disrupts phospholipase Cbeta and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth.
    Beekman A; Helfrich B; Bunn PA; Heasley LE
    Cancer Res; 1998 Mar; 58(5):910-3. PubMed ID: 9500449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC).
    Zhao Q; Gu X; Zhang C; Lu Q; Chen H; Xu L
    Cancer Biol Ther; 2015; 16(4):634-43. PubMed ID: 25778781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles of cholinergic receptors in small cell lung cancer cells.
    Zhang S; Togo S; Minakata K; Gu T; Ohashi R; Tajima K; Murakami A; Iwakami S; Zhang J; Xie C; Takahashi K
    Anticancer Res; 2010 Jan; 30(1):97-106. PubMed ID: 20150622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated cholinergic signaling provides a target in squamous cell lung carcinoma.
    Song P; Sekhon HS; Fu XW; Maier M; Jia Y; Duan J; Proskosil BJ; Gravett C; Lindstrom J; Mark GP; Saha S; Spindel ER
    Cancer Res; 2008 Jun; 68(12):4693-700. PubMed ID: 18559515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
    Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway.
    Péqueux C; Keegan BP; Hagelstein MT; Geenen V; Legros JJ; North WG
    Endocr Relat Cancer; 2004 Dec; 11(4):871-85. PubMed ID: 15613460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
    Wolff NC; Randle DE; Egorin MJ; Minna JD; Ilaria RL
    Clin Cancer Res; 2004 May; 10(10):3528-34. PubMed ID: 15161712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.
    Spruce BA; Campbell LA; McTavish N; Cooper MA; Appleyard MV; O'Neill M; Howie J; Samson J; Watt S; Murray K; McLean D; Leslie NR; Safrany ST; Ferguson MJ; Peters JA; Prescott AR; Box G; Hayes A; Nutley B; Raynaud F; Downes CP; Lambert JJ; Thompson AM; Eccles S
    Cancer Res; 2004 Jul; 64(14):4875-86. PubMed ID: 15256458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective M3 muscarinic receptor antagonist inhibits small-cell lung carcinoma growth in a mouse orthotopic xenograft model.
    Ami N; Koga K; Fushiki H; Ueno Y; Ogino Y; Ohta H
    J Pharmacol Sci; 2011; 116(1):81-8. PubMed ID: 21512307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice.
    Yamada S; Maruyama S; Takagi Y; Uchida S; Oki T
    Life Sci; 2006 Dec; 80(2):127-32. PubMed ID: 16996089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis.
    Nguyen MH; Koinuma J; Ueda K; Ito T; Tsuchiya E; Nakamura Y; Daigo Y
    Cancer Res; 2010 Jul; 70(13):5337-47. PubMed ID: 20551060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of g protein-coupled receptor kinase 6-mediated phosphorylation and regulation of single-cell m3 muscarinic acetylcholine receptor signaling.
    Willets JM; Mistry R; Nahorski SR; Challiss RA
    Mol Pharmacol; 2003 Nov; 64(5):1059-68. PubMed ID: 14573754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
    Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
    Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling.
    Khanzada UK; Pardo OE; Meier C; Downward J; Seckl MJ; Arcaro A
    Oncogene; 2006 Feb; 25(6):877-87. PubMed ID: 16170339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt.
    Yeh J; Litz J; Hauck P; Ludwig DL; Krystal GW
    Lung Cancer; 2008 May; 60(2):166-74. PubMed ID: 18006183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo.
    Langdon S; Sethi T; Ritchie A; Muir M; Smyth J; Rozengurt E
    Cancer Res; 1992 Aug; 52(16):4554-7. PubMed ID: 1379515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of G(alpha)12 and G(alpha)13 for human small cell lung cancer cell proliferation in vitro and tumor growth in vivo.
    Grzelinski M; Pinkenburg O; Büch T; Gold M; Stohr S; Kalwa H; Gudermann T; Aigner A
    Clin Cancer Res; 2010 Mar; 16(5):1402-15. PubMed ID: 20160064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of acetylcholine by lung cancer.
    Song P; Sekhon HS; Proskocil B; Blusztajn JK; Mark GP; Spindel ER
    Life Sci; 2003 Mar; 72(18-19):2159-68. PubMed ID: 12628474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.